Recombinant trivalent poliomyelitis vaccine (Tianjin CanSino Biotechnology)

N/A

Report date: 2025/07/23 11:38:26

Base Information

Drug NameRecombinant trivalent poliomyelitis vaccine (Tianjin CanSino Biotechnology)
Drug Alias NameVirus-like Particle (VLP) Based VaccineSf-RVN cell vaccineVLP-Polio vaccineVLP-Polio
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPoliomyelitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaIndonesia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCanSino Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCanSino Biologics Inc
Inactive CompaniesN/A
Active IndicationsPoliomyelitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A